BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qi F, Liu M, Li F, Lv Q, Wang G, Gong S, Wang S, Xu Y, Bao L, Qin C. Interleukin-37 Ameliorates Influenza Pneumonia by Attenuating Macrophage Cytokine Production in a MAPK-Dependent Manner. Front Microbiol 2019;10:2482. [PMID: 31736917 DOI: 10.3389/fmicb.2019.02482] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Li A, Ling Y, Song Z, Cheng X, Ding L, Jiang R, Fu W, Liu Y, Hu H, Yuan S, Chen J, Zhu C, Fan J, Wang J, Jin Y, Zhang M, Zhu L, Sun P, Zhang L, Qin R, Zhang W, Qiu C, Shen Y, Zhang L, Shi Z, Zhao C, Zhu T, Lu H, Zhang X, Xu J. Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis 2021;223:568-80. [PMID: 33197260 DOI: 10.1093/infdis/jiaa713] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Wang JL, Chen X, Xu Y, Chen YX, Wang J, Liu YL, Song HT, Fei J, Zhao H, Fu L. The Associations of Serum IL-37 With the Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Retrospective Cohort Study. Front Immunol 2021;12:636896. [PMID: 34025645 DOI: 10.3389/fimmu.2021.636896] [Reference Citation Analysis]
3 Law CC, Puranik R, Fan J, Fei J, Hambly BD, Bao S. Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19. Front Cardiovasc Med 2021;8:630767. [PMID: 34422917 DOI: 10.3389/fcvm.2021.630767] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Su Z, Tao X. Current Understanding of IL-37 in Human Health and Disease. Front Immunol 2021;12:696605. [PMID: 34248996 DOI: 10.3389/fimmu.2021.696605] [Reference Citation Analysis]
5 Ochayon DE, Waggoner SN. The Effect of Unconventional Cytokine Combinations on NK-Cell Responses to Viral Infection. Front Immunol 2021;12:645850. [PMID: 33815404 DOI: 10.3389/fimmu.2021.645850] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 van Eeden C, Khan L, Osman MS, Cohen Tervaert JW. Natural Killer Cell Dysfunction and Its Role in COVID-19. Int J Mol Sci 2020;21:E6351. [PMID: 32883007 DOI: 10.3390/ijms21176351] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
7 Murphy-Schafer AR, Paust S. Divergent Mast Cell Responses Modulate Antiviral Immunity During Influenza Virus Infection. Front Cell Infect Microbiol 2021;11:580679. [PMID: 33680987 DOI: 10.3389/fcimb.2021.580679] [Reference Citation Analysis]
8 Ahmed AA, Ad'hiah AH. Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19). Cytokine 2021;148:155702. [PMID: 34534925 DOI: 10.1016/j.cyto.2021.155702] [Reference Citation Analysis]
9 Boersma B, Jiskoot W, Lowe P, Bourquin C. The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy. Cytokine Growth Factor Rev 2021:S1359-6101(21)00071-X. [PMID: 34620560 DOI: 10.1016/j.cytogfr.2021.09.004] [Reference Citation Analysis]
10 Tsuji G, Hashimoto-Hachiya A, Matsuda-Taniguchi T, Takai-Yumine A, Takemura M, Yan X, Furue M, Nakahara T. Natural Compounds Tapinarof and Galactomyces Ferment Filtrate Downregulate IL-33 Expression via the AHR/IL-37 Axis in Human Keratinocytes. Front Immunol 2022;13:745997. [PMID: 35663970 DOI: 10.3389/fimmu.2022.745997] [Reference Citation Analysis]